-- Earnings Flash (RDUS) RADIUS HEALTH Posts Q1 Revenue $43.2M, vs. Street Est of $51.3M
7:31AM ET 5/05/2022 MT Newswires...
...
...
Radius Health (RDUS) said Wednesday that Mark Conley was named as its new chief financial officer Conley most recently served as vice president of finance...
Radius Health (RDUS) said Tuesday it has filed a supplemental new drug application with the US Food and Drug Administration for its Tymlos injection to...
Address | 22 Boston Wharf Road Boston, Massachusetts 02210 |
Phone | +1.617.551.4000 |
Number of Employees | 398 |
Recent SEC Filing | 05/05/2022![]() |
President, Chief Executive Officer & Director | George Kelly Martin |
CFO, Treasurer, Chief Accounting Officer & VP | Mark Conley |
Chief Medical Officer | Bruce Mitlak |
Head-Information Technology | Allison Ross |
Price Open | $5.61 |
Previous Close | $5.84 |
52 Week Range | $4.97 - 23.00 |
Market Capitalization | $277.8 M |
Shares Outstanding | 47.6 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 08/04/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$1.54 |
Beta vs. S&P 500 | N/A |
Revenue | $99.2 M |
Net Profit Margin | -33.52% |
Return on Equity | 29.44% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |